StemoniX
is a biotechnology company that develops human iPSC-based screening products for pharmaceutical and research organizations... Read moreStemoniX
is a biotechnology company that develops human iPSC-based screening products for pharmaceutical and research organizations... Read more
News
Oct 23, 2023
Outsourcing-Pharma
StemoniX: AxoSim's acquisition of microBrain to transform neurological R&D
Jul 17, 2023
Contract Pharma
StemoniX: AxoSim Acquires Vyant Bio's StemoniX Assets for $2.25M
Apr 24, 2021
Global Legal Chronicle
StemoniX: StemoniX's Merger with Cancer Genetics
Apr 01, 2021
Markets Insider
StemoniX: Vyant Bio Announces Investor Webcast to Provide Updates Post Merger between Cancer Genetics and StemoniX
Mar 25, 2021
BioSpace
StemoniX: Cancer Genetics Announces Shareholder Approval of All Proposals in Connection with the Proposed Merger with StemoniX
Jan 11, 2021
FinanzNachrichten
StemoniX: StemoniX to Participate in Biotech Showcase Digital 2021
Nov 13, 2020
Accesswire
Press Release: StemoniX : StemoniX Announces Publication Demonstrating High-throughput Screening Using Human-derived CNS Models
Oct 19, 2020
Accesswire
Press Release: StemoniX : StemoniX Announces Addition to Board of Directors
Sep 15, 2020
MarketScreener
StemoniX: Cancer Genetics : Investor Presentation
Aug 26, 2020
Business Wire
Press Release: StemoniX : CANCER GENETICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Cancer Genetics, Inc. - CGIX
StemoniX Competitors
1
2
3
4
5
6
7
8
9
10